Quick Answer
Niagen Bioscience, Inc. reported Total Revenue of $129.42 million for fiscal year 2025.
Niagen Bioscience, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $129.42M | +29.9% |
| 2024 | $99.60M | +19.2% |
| 2023 | $83.57M | +16.0% |
| 2022 | $72.05M | +6.8% |
| 2021 | $67.45M | +13.8% |
| 2020 | $59.26M | +28.0% |
| 2019 | $46.29M | +46.7% |
| 2018 | $31.56M | +48.8% |
| 2017 | $21.20M | -2.1% |
| 2016 | $21.66M | +21.1% |
| 2015 | $17.88M | +16.8% |
| 2014 | $15.31M | +50.7% |
| 2013 | $10.16M | -12.5% |
| 2012 | $11.61M | +43.1% |
| 2011 | $8.11M | +7.2% |
| 2010 | $7.57M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $33.99M | +32.9% | +9.2% |
| June 30, 2025 | $31.12M | +36.8% | +2.1% |
| March 31, 2025 | $30.48M | +37.6% | +19.2% |
| September 30, 2024 | $25.58M | +31.2% | +12.5% |
| June 30, 2024 | $22.74M | +11.9% | +2.6% |
| March 31, 2024 | $22.15M | -1.8% | +13.6% |
| September 30, 2023 | $19.50M | +14.3% | -4.1% |
| June 30, 2023 | $20.32M | +21.5% | -9.9% |
- Niagen Bioscience, Inc. showed an increase of +29.9% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2025 period, Niagen Bioscience, Inc.’s total revenue has grown by 1610.5% (from $7.57 million to $129.42 million).
- The most recent figure is from Niagen Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: